Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Bevirimat (PA-457) is a first-in-class inhibitor of HIV-1 maturation, blocking the cleavage of the Gag capsid (CA) precursor, CA-SPI, to mature CA protein during virion maturation.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 47.00 | |
5 mg | In stock | $ 97.00 | |
10 mg | In stock | $ 163.00 | |
25 mg | In stock | $ 363.00 | |
50 mg | In stock | $ 538.00 | |
100 mg | In stock | $ 768.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 125.00 |
Description | Bevirimat (PA-457) is a first-in-class inhibitor of HIV-1 maturation, blocking the cleavage of the Gag capsid (CA) precursor, CA-SPI, to mature CA protein during virion maturation. |
In vivo | PA-457 reduced viral load in HIV-infected adults in a dose-dependent fashion, when given in a single oral dose in a clinical study[1]. |
Source |
Synonyms | YK FH312, MPC-4326, PA-457 |
Molecular Weight | 584.83 |
Formula | C36H56O6 |
CAS No. | 174022-42-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (85.49 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bevirimat 174022-42-5 Microbiology/Virology Proteases/Proteasome HIV Protease YK FH312 YK FH 312 Human immunodeficiency virus MPC-4326 MPC 4326 PA-457 PA 457 HIV YK FH-312 Inhibitor PA457 inhibit MPC4326 inhibitor